Top Tweets for #TeCARTus
Today, @NICEComms has announced that it will reconsider its decision to recommend the removal of #tecartus for the treatment of relapsed or refractory mantle cell #Lymphoma.
Lymphoma Action, together with @AnthonyNolan and @bloodcancer_uk, submitted a formal appeal against...
We're proud to be continuing to work alongside @AnthonyNolan and @BloodCancer_UK on this important issue. #Tecartus
Together with @LymphomaAction & @BloodCancer_UK, we’ve written to Health Secretary @WesStreeting to urgently review NICE’s decision to remove Tecartus as a treatment option for people with mantle cell lymphoma.
Lymphoma Action, together with @AnthonyNolan and @bloodcancer_uk, are calling on NICE to reconsider its decision to remove the CAR T-cell therapy brexucabtagene autoleucel (brexu-cel) as a treatment for mantle cell lymphoma. Read more: https://t.co/sz5hglLr17 @NICEComms #Tecartus
With #CAR-T therapies like #Kymriah, #Yescarta and #Tecartus revolutionizing #bloodcancers, next-gen approaches are aiming to tackle #solidtumors—focused on enhancing persistence, precision targeting and navigating the suppressive #tumor microenvironment. #Oncology #Immunotherapy
@Larvol highlights CAR-T products with abstract numbers ahead of the @ASCO 2025, including study names, targets, diseases, type of data release, and companies.
#LARVOL #ASCO25 #CancerResearch #Oncology #OncologyInsights #CancerData #CancerCare #Hematology #SolidTumor #CART
Connect with some of the top voices of Heme-Onc and solid tumor on X: @VivekSubbiah | @Dr_R_Kurzrock | @VincentRK | @doctorpemm | @Rfonsi1 | @pashtoonkasi | @YJanjigianMD | @DrChoueiri | @StephenVLiu | @mtmdphd | @SuyogCancer
📣RECUERDA que tenemos #Masterclass #LaFHactoria: 𝘼𝙘𝙩𝙪𝙖𝙡𝙞𝙯𝙖𝙘𝙞ó𝙣 𝙚𝙣 𝙚𝙡 𝙩𝙧𝙖𝙩𝙖𝙢𝙞𝙚𝙣𝙙𝙤 𝙘𝙤𝙣 𝘾𝘼𝙍-𝙏: 𝙔𝙚𝙨𝙘𝙖𝙧𝙩𝙖 𝙮 𝙏𝙚𝙘𝙖𝙧𝙩𝙪𝙨 👩🏻⚕️Dra. Marta Villalba hematóloga 🏥HUP La Fe
#FormaciónSanitaria #Hematología #TerapiaAvanzadas #Yescarta #Tecartus
Check out this large U.S. consortium study describing how prior inotuzumab exposure relates to outcomes in patients with #ALL receiving #Tecartus, recently published in @BloodAdvances and featuring our faculty @ChenyuLinMD! #ROCCA #leusm #CART
👉https://t.co/AHNxkNdqqQ👈
Wonderful meeting today in #Madrid @GileadSciences @KitePharma
#YesCARTa and #TeCARTus new approved indications in #Spain. Great results and amazing opportunities for our #Lymphoma patients #MCL #DLBCL #FL
Continued from👆#FDA Safety Labeling Change Notification Letters to CAR T manufacturers: https://t.co/MgKRscGmsj
#ABECMA (idecabtagene vicleucel)
#BREYANZI (lisocabtagene maraleucel)
#CARVYKTI (ciltacabtagene autoleucel)
#KYMRIAH (tisagenlecleucel)
#TECARTUS (brexucabtagene autoleucel)
#YESCARTA (axicabtagene ciloleucel)
#Francenews -#HAS stated that #Tecartus showed no improvement vs SoC in #ALL patients
https://t.co/rSyCS5MY45
#france #médicament #patientcare #globalhealth #marketaccess #remboursement #Pharma #pharmaceutical #healthcare #globalhealth #Patientcare #news #media #publichealth
How much does Tecartus cost? Chimeric antigen receptor (CAR) T-cell therapy is an #immunotherapy that uses a patient’s own genetically modified T cells (white blood cells), to find and kill cancer. It's an advanced treatment, but it's costly. https://t.co/7Bf4cdrp8p #Tecartus
Kite, компания #Gilead, объявила результаты трёхлетнего исследования CAR T-клеточной терапии Tecartus против острого лимфобластного лейкоза. Данные были представлены на 5-м европейском собрании CAR T-клеток в Нидерландах. #Онкология #Лейкоз #Tecartus https://t.co/W2wz7XCsN7
Is Tecartus a one-time treatment? CAR T-cell therapy is not a "drug" in the usual sense, as might be used to treat pain or an infection. Instead, it is a living biologic medicine (#immunotherapy) created from your own cells. https://t.co/nFsjRmr0Ai #Tecartus #lymphoma #leukemia
Each week we round up the latest #CellTherapy news, from the gene therapy manufacturing collaboration between @CRiverLabs and @CureAP4 to the European marketing authorization of #Tecartus. Get more regenerative medicine updates on RegMedNet>>>
https://t.co/AcTtLYClrB
Summary of US Food and Drug Administration CAR-T-Cell Biologics License Application Approvals From a Statistical Perspective https://t.co/s20qQ9XHV6
#CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy #Gene #Genetherapy
@ASTCT @JCO_ASCO
Wonder when Europe will get it?
Last Seen Hashtags on Sotwe
pascalnichols
Seen from United States
抖音主播
Seen from Korea
podereclamar
Seen from United States
MissaChrismatis
Seen from United States
schuberthelmete1
Seen from United States
broem
Seen from United States
momsonn
Seen from United States
συριζα_xeftiles
Seen from United States
ONEPIECERAWS
Seen from United States
Zeehondencentrum
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.9M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.1M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.1M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers